Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00483717
Status:
COMPLETED
Last Update Posted:
2016-09-30
First Post:
2007-06-05
Brief Title:
Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine
Sponsor:
Egalet Ltd
Organization:
Egalet Ltd
Study Overview
Official Title:
A Phase 2 Double-blind Randomized Placebo-controlled Study of the Safety Tolerability and Analgesic Efficacy of Ketorolac Tromethamine Administered Intranasally for the Acute Treatment of Migraine
Status:
COMPLETED
Status Verified Date:
2016-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study evaluates the efficacy and safety of using ketorolac as a nasal spray for the acute treatment of migraine
Detailed Description:
Evaluates the efficacy and safety of using ketorolac as a nasal spray for the acute treatment of migraine
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None